141 related articles for article (PubMed ID: 3032858)
1. The influence of the charge and of the tin-ligand ratio on bone uptake of technetium 99m labelled osteotropic radiopharmaceuticals.
Gouaillardou D; Conti ML
Int J Rad Appl Instrum A; 1987; 38(2):103-6. PubMed ID: 3032858
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
4. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
[No Abstract] [Full Text] [Related]
6. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
8. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
[TBL] [Abstract][Full Text] [Related]
9. A comment on "Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism".
Caniggia A; Vattimo A
Calcif Tissue Int; 1983; 35(2):261. PubMed ID: 6850407
[No Abstract] [Full Text] [Related]
10. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
Coupal JJ
Calcif Tissue Int; 1981; 33(5):555. PubMed ID: 6797708
[No Abstract] [Full Text] [Related]
11. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
13. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
14. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
[No Abstract] [Full Text] [Related]
15. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
Baum RP; Brandhorst I; Maul FD; Hör G
Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
[No Abstract] [Full Text] [Related]
16. [Accumulation of sodium 2,3-dicarboxypropan-1,1-diphosphonate in bone of rabbits (author's transl)].
Nagai K; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Muranaka A; Ito Y
Radioisotopes; 1982 Apr; 31(4):197-8. PubMed ID: 6213983
[No Abstract] [Full Text] [Related]
17. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
Anger K; Aigner S; Bühler M; Umbach I
Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
19. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow.
Sagar VV; Piccone JM; Charkes ND
J Nucl Med; 1979 Dec; 20(12):1257-61. PubMed ID: 536792
[TBL] [Abstract][Full Text] [Related]
20. Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.
Archimandritis SC; Tsolis AK
Eur J Nucl Med; 1987; 13(3):134-8. PubMed ID: 3622557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]